🩺 Managing Malignant Germ Cell Tumours: Key Insights and Surveillance Strategies
🩺 Managing Malignant Germ Cell Tumours: Key Insights and Surveillance Strategies Malignant ovarian germ cell tumours (MOGCTs) are a rare yet critical subset of ovarian cancers, constituting 1.5% of cases in Europe. With approximately 100 diagnoses annually in the UK, effective management and meticulous follow-up are essential. Here are some crucial points and surveillance strategies for managing MOGCTs: 🔍 Early Detection and Treatment - Prevalence: MOGCTs represent 1.5% of ovarian cancers in Europe. - Early Diagnosis: 60-70% are diagnosed at an early stage. - Initial Treatment: Typically treated with surgery followed by active surveillance or adjuvant chemotherapy. - Chemotherapy Sensitivity: MOGCTs are more responsive to chemotherapy compared to other ovarian tumour 🏥 Surgical Considerations - Radical Surgery: Recommended for women who have completed their family or are beyond childbearing age, including total hysterectomy and bilateral salpingo-oophorectomy. - Less Invasive